Key Points
- CEO Celeste Beeks Mastin bought 5,170 shares on April 7 at an average price of $57.08, a $295,103.60 transaction that increased her direct stake to 8,670 shares (a 147.71% increase).
- H. B. Fuller beat Q1 EPS estimates with $0.57 per share while revenue fell 2.3% year‑over‑year to $770.8 million; the company has a market cap of about $3.14 billion and a P/E near 19.1.
- Analyst sentiment is positive — consensus rating "Moderate Buy" with an average price target of $65.50 — and the stock trades in a 52‑week range of $47.56–$68.63 with a ~1.6% dividend yield.
H. B. Fuller Company (NYSE:FUL - Get Free Report) CEO Celeste Beeks Mastin acquired 5,170 shares of the firm's stock in a transaction dated Tuesday, April 7th. The shares were acquired at an average price of $57.08 per share, for a total transaction of $295,103.60. Following the acquisition, the chief executive officer directly owned 8,670 shares of the company's stock, valued at approximately $494,883.60. The trade was a 147.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
H. B. Fuller Price Performance
FUL stock opened at $57.71 on Wednesday. H. B. Fuller Company has a 52-week low of $47.56 and a 52-week high of $68.63. The stock's fifty day simple moving average is $61.08 and its 200-day simple moving average is $59.97. The company has a quick ratio of 1.15, a current ratio of 1.92 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of 19.05, a price-to-earnings-growth ratio of 0.80 and a beta of 1.05.
H. B. Fuller (NYSE:FUL - Get Free Report) last posted its quarterly earnings data on Wednesday, March 25th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.01. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The business had revenue of $770.84 million for the quarter, compared to analysts' expectations of $787.77 million. During the same quarter last year, the firm earned $0.54 earnings per share. The business's revenue was down 2.3% on a year-over-year basis. Equities research analysts expect that H. B. Fuller Company will post 4.07 EPS for the current year.
H. B. Fuller Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 19th. Stockholders of record on Thursday, February 5th were issued a dividend of $0.235 per share. The ex-dividend date was Thursday, February 5th. This represents a $0.94 annualized dividend and a dividend yield of 1.6%. H. B. Fuller's dividend payout ratio (DPR) is 31.02%.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. Salomon & Ludwin LLC purchased a new position in H. B. Fuller in the third quarter valued at about $28,000. Allworth Financial LP raised its position in H. B. Fuller by 50.1% in the fourth quarter. Allworth Financial LP now owns 578 shares of the specialty chemicals company's stock valued at $34,000 after purchasing an additional 193 shares during the period. Covestor Ltd raised its position in H. B. Fuller by 22,833.3% in the third quarter. Covestor Ltd now owns 688 shares of the specialty chemicals company's stock valued at $41,000 after purchasing an additional 685 shares during the period. Hantz Financial Services Inc. raised its position in H. B. Fuller by 432.9% in the fourth quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company's stock valued at $46,000 after purchasing an additional 632 shares during the period. Finally, Aster Capital Management DIFC Ltd purchased a new position in H. B. Fuller in the fourth quarter valued at about $46,000. 95.93% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
FUL has been the topic of several analyst reports. Citigroup raised their price objective on H. B. Fuller from $67.00 to $70.00 and gave the stock a "buy" rating in a report on Monday, March 30th. Vertical Research raised H. B. Fuller from a "hold" rating to a "strong-buy" rating in a research report on Friday, March 27th. Wall Street Zen raised H. B. Fuller from a "hold" rating to a "buy" rating in a research report on Sunday, March 29th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of H. B. Fuller in a research report on Monday, December 29th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of H. B. Fuller in a research report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $65.50.
Get Our Latest Stock Analysis on H. B. Fuller
About H. B. Fuller
(
Get Free Report)
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller's product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
